Hereditary Hemochromatosis

被引:3
作者
Crownover, Brian K. [1 ]
Covey, Carlton J. [2 ]
机构
[1] Nellis Family Med Residency, Med Grp 99, Nellis AFB, NV USA
[2] Nellis Family Med Residency, Nellis AFB, NV USA
关键词
LONG-TERM SURVIVAL; IRON-OVERLOAD; GENETIC HEMOCHROMATOSIS; NONINVASIVE PREDICTION; MAMMARY CARCINOGENESIS; ASYMPTOMATIC SUBJECTS; HEPATIC-FIBROSIS; DIETARY IRON; DIAGNOSIS; PATHOPHYSIOLOGY;
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Hereditary hemochromatosis is an autosomal recessive disorder that disrupts the body's regulation of iron. It is the most common genetic disease in whites. Men have a 24-fold increased rate of iron-overload disease compared with women. Persons who are homozygous for the HFE gene mutation C282Y comprise 85 to 90 percent of phenotypically affected persons. End-organ damage or clinical manifestations of hereditary hemochromatosis occur in approximately 10 percent of persons homozygous for C282Y. Symptoms of hereditary hemochromatosis are nonspecific and typically absent in the early stages. If present; symptoms may include weakness, lethargy, arthralgias, and impotence. Later manifestations include arthralgias, osteoporosis, cirrhosis, hepatocellular cancer, cardiomyopathy, dysrhythmia, diabetes mellitus, and hypogonadism. Diagnosis requires confirmation of increased serum ferritin levels and transferrin saturation, with or without symptoms. Subtyping is based on genotypic expression. Serum ferritin measurement is the most useful prognostic indicator of disease severity. Liver biopsy is performed to stage the degree of fibrosis with severe ferritin elevation or transaminitis, or to diagnose nonclassical hereditary hemochromatosis in patients with other genetic defects. Treatment of hereditary hemochromatosis requires phlebotomy, and the frequency is guided by serial measurements of serum ferritin levels and transferrin saturation. Iron avidity can result from overtreatment. If iron avidity is not suspected, it may mimic undertreatment with persistently elevated transferrin saturation. Dietary modification is generally unnecessary. Universal screening for hereditary hemochromatosis is not recommended, but testing should be performed in first-degree relatives of patients with classical HFE-related hemochromatosis, those with evidence of active liver disease, and patients with abnormal iron study results. Screening for hepatocellular carcinoma is reserved for those with hereditary hemochromatosis and cirrhosis. (Am Earn Physician. 2013; 87(3) :183-190. Copyright (C) 2013 American Academy of Family Physicians.)
引用
收藏
页码:183 / 190
页数:8
相关论文
共 46 条
[1]   Biological variability of transferrin saturation and unsaturated iron-binding capacity [J].
Adams, Paul C. ;
Reboussin, David M. ;
Press, Richard D. ;
Barton, James C. ;
Acton, Ronald T. ;
Moses, Godfrey C. ;
Leiendecker-Foster, Catherine ;
McLaren, Gordon D. ;
Dawkins, Fitzroy W. ;
Gordeuk, Victor R. ;
Lovato, Laura ;
Eckfeldt, John H. .
AMERICAN JOURNAL OF MEDICINE, 2007, 120 (11) :999.e1-999.e7
[2]   Hemochromatosis and iron-overload screening in a racially diverse population [J].
Adams, PC ;
Reboussin, DM ;
Barton, JC ;
McLaren, CE ;
Eckfeldt, JH ;
McLaren, GD ;
Dawkins, FW ;
Acton, RT ;
Harris, EL ;
Gordeuk, VR ;
Leiendecker-Foster, C ;
Speechley, M ;
Snively, BM ;
Holup, JL ;
Thomson, E ;
Sholinsky, P ;
Acton, RT ;
Barton, JC ;
Dixon, D ;
Rivers, CA ;
Tucker, D ;
Ware, JC ;
McLaren, CE ;
McLaren, GD ;
Anton-Culver, H ;
Baca, JA ;
Bent, TC ;
Brunner, LC ;
Dao, MM ;
Jorgensen, KS ;
Kuniyoshi, J ;
Le, HD ;
Masatsugu, MK ;
Meyskens, FL ;
Morohashi, D ;
Nguyen, HP ;
Panagon, SN ;
Phung, C ;
Raymundo, V ;
Ton, T ;
Walker, AP ;
Wenzel, LB ;
Ziogas, A ;
Adams, PC ;
Bloch, E ;
Chakrabarti, S ;
Fleischhauer, A ;
Harrison, H ;
Jia, K ;
Larson, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (17) :1769-1778
[3]   LONG-TERM SURVIVAL ANALYSIS IN HEREDITARY HEMOCHROMATOSIS [J].
ADAMS, PC ;
SPEECHLEY, M ;
KERTESZ, AE .
GASTROENTEROLOGY, 1991, 101 (02) :368-372
[4]   Iron-overload-related disease in HFE hereditary hemochromatosis [J].
Allen, Katrina J. ;
Gurrin, Lyle C. ;
Constantine, Clare C. ;
Osborne, Nicholas J. ;
Delatycki, Martin B. ;
Nicoll, Amanda J. ;
McLaren, Christine E. ;
Bahlo, Melanie ;
Nisselle, Amy E. ;
Vulpe, Chris D. ;
Anderson, Gregory J. ;
Southey, Melissa C. ;
Giles, Graham G. ;
English, Dallas R. ;
Hopper, John L. ;
Olynyk, John K. ;
Powell, Lawrie W. ;
Gertig, Dorota M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (03) :221-230
[5]  
American Academy of Family Physicians, HEM
[6]  
American Red Cross, EL CRIT ALPH LIST
[7]   Medical progress: Disorders of iron metabolism [J].
Andrews, NC .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (26) :1986-1995
[8]   Hepcidin: The missing link between hemochromatosis and infections [J].
Ashrafian, H .
INFECTION AND IMMUNITY, 2003, 71 (12) :6693-6700
[9]   HFE genotype in patients with hemochromatosis and other liver diseases [J].
Bacon, BR ;
Olynyk, JK ;
Brunt, EM ;
Britton, RS ;
Wolff, RK .
ANNALS OF INTERNAL MEDICINE, 1999, 130 (12) :953-962
[10]   Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases [J].
Bacon, Bruce R. ;
Adams, Paul C. ;
Kowdley, Kris V. ;
Powell, Lawrie W. ;
Tavill, Anthony S. .
HEPATOLOGY, 2011, 54 (01) :328-343